Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues

Bioanalysis

Volumn 6, Issue 12, 2014, Pages 1657-1677

  Naz, Shama ^a   Moreira Dos Santos, Délia Chaves ^a,b   García, Antonia ^a   Barbas, Coral ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; BLADDER; BONE TISSUE; BRAIN TISSUE; BREAST; CAPILLARY ELECTROPHORESIS; CAPILLARY ELECTROPHORESIS MASS SPECTROMETRY; CENTRIFUGATION; CHEMICAL ANALYSIS; COLON; DERIVATIZATION; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; EYE; FREEZE DRYING; HEAD; HEART; HIPPOCAMPUS; HOMOGENIZATION; INTESTINE; KIDNEY PARENCHYMA; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; LIVER; LUNG PARENCHYMA; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; METABOLITE; METABOLOMICS; MULTIVARIATE ANALYSIS; MUSCLE TISSUE; NECK; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PANCREAS; PLACENTA; PROSTATE TISSUE; QUORUM SENSING; REPRODUCIBILITY; REVIEW; SARCOMA; SEPARATION TECHNIQUE; SKIN TISSUE; SOLID PHASE MICROEXTRACTION; SPINAL CORD; SPLEEN; TESTIS; TISSUES; ANIMAL; HISTOLOGY; HUMAN; PROCEDURES;

ANIMALS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, CAPILLARY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; METABOLOMICS;

EID: 84905442962     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.119     Document Type: Review

References (110)

1. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genomics 2(3), 155-168 (2001).
2. Nicholson JK, Wilson ID. Opinion: Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2(8), 668-677 (2003).
3. Nicholson J K, Lindon JC. Systems biology: Metabonomics. Nature 455, 1054-1056 (2008).
4. Fiehn O. Metabolomics-The link between genotypes and phenotypes. Plant Mol. Biol. 48(1-2), 155-171 (2002).
5. Lundström SL, Levänen B, Nording M et al. Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure. PLoS ONE 6(8), e23864 (2011).
6. Scholz M, Gatzek S, Sterling A, Fiehn O, Selbig J. Metabolite fingerprinting: Detecting biological features by independent component analysis. Bioinformatics 20(15), 2447-2454 (2004).
7. Kind T, Fiehn O. Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformat. 7, 234 (2006).
8. Kim JW, Ryu SH, Kim S et al. Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary (1)H NMR-based metabolomics in humans. Anal. Chem. 85(23), 11326-11334 (2013).
9. Naz S, Garcia A, Rusak M, Barbas C. Method development and validation for rat serum fingerprinting with CE-MS: Application to ventilator-induced-lung- injury study. Anal. Bioanal. Chem. 405(14), 4849-4858 (2013).
10. Naz S, Garcia A, Barbas C. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue. Anal. Chem. 85(22), 10941-10948 (2013).
11. Balderas C, Rupérez FJ, Ibañez E et al. Plasma and urine metabolic fingerprinting of Type 1 diabetic children. Electrophoresis 34(19), 2882-2890 (2013).
12. Sen Y, Wang K, Chiu L et al. Metabolic phenotype of the healthy rodent model using in-vial extraction of dried serum, urine, and cerebrospinal fluid spots. Anal. Chem. 85(15), 7257-7263 (2013).
13. Yonezawa K, Nishiumii S, Kitamoto-Matsuda J et al. Serum and tissue metabolomics of head and neck cancer. Cancer Genom. Proteom. 10(5), 233-238 (2013).
14. Huang Q, Yin P, Wang J et al. Method for liver tissue metabolic profiling study and its application in Type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(13-14), 961-967 (2011).
15. Ganti S, Taylor SL, Abu A et al. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res. 72(14), 3471-3479 (2012).
16. Hori S, Nishiumi S, Kobayashi K et al. A metabolomic approach to lung cancer. Lung Cancer 74(2), 284-292 (2011).
17. Sugimoto M, Ikeda S, Niigata K, Tomita M, Sato H, Soga T. MMMDB: Mouse multiple tissue metabolome database. Nucleic Acids Res. 40(Database issue), D809-D814 (2012).
18. Gang S, Kui Y, Zhongdan Z, Shaoping G, Xianlin H, Richard WG. Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. Anal. Chem. 79(17), 6629-6640 (2007).
19. Luke CM, Stephen CK, Rong T, Robert ES. Sample preparation methodology for mouse heart metabolomics using comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry. Talanta 108, 123-130 (2013).
20. Mal M, Koh PK, Cheah PY, Chan EC. Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun. Mass Spectrom. 23(4), 487-489 (2009).
21. Adahchour M, Beens J, Brinkman UA. Recent developments in the application of comprehensive two-dimensional gas chromatography. J. Chromatogr. A 1186(1-2), 67-108 (2008).
22. Nikolskiy I, Mahieu NG, Chen YJ, Tautenhahn R, Patti GJ. An untargeted metabolomic workflow to improve structural characterization of metabolites. Anal. Chem. 85, 7713-7719 (2013).
23. García-Heredia A, Kensicki E, Mohney RP et al. Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: A metabolomic approach. J. Proteome Res. 12(4), 1946-1955 (2013).
24. McBurney RN, Hines WM, Von Tungeln LS et al. The liver toxicity biomarker study Phase I: Markers for the effects of tolcapone or entacapone. Toxicol. Pathol. 40(6), 951-964 (2012).
25. Lin S, Liu H, Kanawati B et al. Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice. Anal. Bioanal. Chem. 405, 5105-5117 (2013).
26. Yabushita S, Fukamachi K, Tanaka H et al. Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcenomas. Carcinogenesis 34(6), 1251-1259 (2013).
27. Hanzu FA, Vinaixa M, Papageorgiou A et al. Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: An untargeted metabolomics approach. Obesity 22(3), 698-704 (2013).
28. Shimura D, Nakai G, Jiao Q et al. Metabolomic profiling analysis reveals chamber-dependent metabolite patterns in the mouse heart. Am. J. Physiol. Heart Circ. Physio. 305(4), H494-H505 (2013).
29. Boudonck KJ, Mitchell MW, Német L et al. Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol. Pathol. 37(3), 280-292 (2009).
30. Baumgarner BL, Cooper BR. Evaluation of a tandem gas chromatography/time- of-flight mass spectrometry metabolomics platform as a single method to investigate the effect of starvation on whole-Animal metabolism in rainbow trout (Oncorhynchus mykiss). J. Exp. Biol. 215(Pt 10), 1627-1632 (2012).
31. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189 (1999).
32. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153-161 (2002).
33. Gray H, Lewis WH. Gray's Anatomy of the Human Body (20th Edition). Bartleby, New York, NY, USA (2000).
34. Brauer HA, Makowski L, Hoadley KA et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin. Cancer Res. 19(3), 571-585 (2013).
35. Laws ER, Parney IF, Huang W et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J. Neurosurg. 99(3), 467-473 (2003).
36. Zhang WY, Liu S, Li HD, Cai HL. Chronic unpredictable mild stress affects myocardial metabolic profiling of SD rats. J. Pharm. Biomed. Anal. 70, 534-438 (2012).
37. Ly-Verdú S, Schaefer A, Kahle M et al. The impact of blood on liver metabolite profiling-A combined metabolomic and proteomic approach. Biomed. Chromatogr. 28(2), 231-240 (2013).
38. Zhang G, He P, Tan H, Budhu A et al. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin. Cancer Res. 19(18), 4983-4993 (2013).
39. Figueroa JD, Cordero K, Serrano-Illan M et al. Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury. Neuroscience 255C, 1-18 (2013).
40. Zhao T, Zhang H, Zhao T et al. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. J. Pharm. Biomed. Anal. 60, 32-43 (2012).
41. Chintapalli VR, Al Bratty M, Korzekwa D et al. Mapping an atlas of tissue-specific Drosophila melanogaster metabolomes by high resolution mass spectrometry. PLoS ONE 8(10), e78066 (2013).
42. Masson P, Alves AC, Ebbels TM, Nicholson JK, Want EJ. Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Anal. Chem. 82, 7779-7786 (2010).
43. Masson P, Spagou K, Nicholson JK, Want EJ. Technical and biological variation in UPLC-MS-based untargeted metabolic profiling of liver extracts: Application in an experimental toxicity study on galactosamine. Anal. Chem. 83, 1116-1123 (2011).
44. Liang X, Ubhayakar S, Liederer BM et al. Evaluation of homogenization techniques for the preparation of mouse tissue samples to support drug discovery. Bioanalysis 3, 1923-1933 (2011).
45. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959).
46. Le Belle JE, Harris NG, Williams SR, Bhakoo KK. A comparison of cell and tissue extraction techniques using high resolution 1H-NMR spectroscopy. NMR Biomed. 15, 37-44 (2002).
47. Matyash V, Liebisch G, Kurzchalia TV, Schevchenko A, Schwudke D. Lipid extraction by methyl-Tert-butyl ether for high-Throughput lipidomics. J. Lipid Res. 49(5), 1137-1146 (2008).
48. Wu H, Southam AD, Hines A, Viant MR. High-Throughput tissue extraction protocol for NMR-And MS-based metabolomics. Anal. Biochem. 372(2), 204-212 (2008).
49. Want EJ, Masson P, Michopoulos F et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat. Protoc. 8, 17-32 (2013).
50. Kirwan JA, Broadhurst DI, Davidson RL, Viant MR. Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow. Anal. Bioanal. Chem. 405(15), 5147-5157 (2013).
51. Yamatani H, Takahashi K, Yoshida T, Soga T, Kurachi H. Differences in the fatty acid metabolism of visceral adipose tissue in postmenopausal women. Menopause 21(2), 170-176 (2014).
52. Ji B, Ernest B, Gooding JR, Das S et al. Transcriptomic and metabolomic profiling of chicken adipose tissue in response to insulin neutralization and fasting. BMC Genomics 13, 41 (2012).
53. Putluri N, Shojaie A, Vasu VT et al. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer Res. 71(24), 7376-7386 (2011).
54. Thysell E, Surowiec I, Hörnberg E et al. Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS ONE 5(12), e14175 (2010).
55. Wang X, Zeng C, Lin J et al. Metabonomics approach to assessing the modulatory effects of St John's Wort, ginsenosides, and clomipramine in experimental depression. J. Proteome Res. 11(12), 6223-6230 (2012).
56. Graham SF, Chevallier OP, Roberts D, Hölscher C, Elliott CT, Green BD. Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease. Anal. Chem. 85(3), 1803-1811 (2013).
57. Epstein AA, Narayanasamy P, Dash PK et al. Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J. Neuroimmune Pharmacol. 8(5), 1224-1238 (2013).
58. van Vliet E, Eixarch E, Illa M et al. Metabolomics reveals metabolic alterations by intrauterine growth restriction in the fetal rabbit brain. PLoS ONE 8(5), e64545 (2013).
59. Kopp F, Komatsu T, Nomura DK et al. The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(-/-) mice. Chem. Biol. 17(8), 831-840 (2010).
60. García-Cañaveras JC, Donato MT, Castell JV, Lahoz A. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J. Proteome Res. 10(10), 4825-4834 (2011).
61. Lv H, Palacios G, Hartil K, Kurland IJ. Advantages of tandem LC-MS for the rapid assessment of tissue-specific metabolic complexity using a pentafluorophenylpropyl stationary phase. J. Proteome Res. 10(4), 2104-2112 (2011).
62. Fenli S, Feng W, Ronghua Z, Huande L. Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression. Eur. Rev. Med. Pharmacol. Sci. 17(1), 41-48 (2013).
63. Baur P, Martin FP, Gruber L et al. Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(?ARE/WT) mouse model. J. Proteome Res. 10(12), 5523-5535 (2011).
64. Maekawa K, Hirayama A, Iwata Y et al. Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy. J. Mol. Cell Cardiol. 59, 76-85 (2013).
65. Montrose DC, Zhou XK, Kopelovich L et al. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev. Res. (Phila). 5(12), 1358-1367 (2012).
66. Liu Y, Yan S, Ji C et al. Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. Kidney Blood Press Res. 35(5), 373-381 (2012).
67. Mains J, Tan LE, Zhang T, Young L, Shi R, Wilson C. Species variation in small molecule components of animal vitreous. Invest. Ophthalmol. Vis. Sci. 53(8), 4778-4786 (2012).
68. Brauer HA, Makowski L, Hoadley KA et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin. Cancer. Res. 19(3), 571-585 (2013).
69. Chen S, Hoene M, Li J et al. Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J. Chromatogr. A. 1298, 9-16 (2013).
70. Holst S, Stavenhagen K, Balog CI et al. Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrixassisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS). Mol. Cell Proteomics 12(11), 3081-3093 (2013).
71. Huang Q, Tan Y, Yin P et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 73(16), 4992-5002 (2013).
72. Budczies J, Brockmöller SF, Müller BM et al. Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: Alterations in glutamine and beta-Alanine metabolism. J. Proteomics 94, 279-288 (2013).
73. McDunn JE, Li Z, Adam KP et al. Metabolomic signatures of aggressive prostate cancer. Prostate 73(14), 1547-1560 (2013).
74. Denkert C, Budczies J, Weichert W et al. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol. Cancer 7, 72 (2008).
75. Kami K, Fujimori T, Sato H et al. Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry. Metabolomics 9(2), 444-453 (2013).
76. Mal M, Koh PK, Cheah PY, Chan EC. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal. Bioanal. Chem. 403(2), 483-493 (2012).
77. Koek MM, van der Kloet FM, Kleemann R, Kooistra T, Verheij ER, Hankemeier T. Semi-Automated non-Target processing in GC GC-MS metabolomics analysis: Applicability for biomedicalstudies. Metabolomics 7(1), 1-14 (2011).
78. Chan EC, Koh PK, Mal M et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8(1), 352-361 (2009).
79. Song H, Wang L, Liu HL et al. Tissue metabolomics fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity. Oncol. Rep. 26(2), 431-438 (2011).
80. Beyoǧlu D, Imbeaud S, Maurhofer O. Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology 58(1), 229-238 (2013).
81. Chuang HL, Huang YT, Chiu CC et al. Metabolomics characterization of energy metabolism reveals glycogen accumulation in gut-microbiota-lacking mice. J. Nutr. Biochem. 23(7), 752-758 (2012).
82. Gu S, A J, Wang G et al. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia. Biomed. Chromatogr. 24(3), 245-252 (2010).
83. Sakai A, Nishiumi S, Shiomi Y et al. Metabolomic analysis to discover candidate therapeutic agents against acute pancreatitis. Arch. Biochem. Biophys. 522(2), 107-120 (2012).
84. Heazell AE, Brown M, Dunn WB et al. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta 29(8), 691-698 (2008).
85. Catchpole G, Platzer A, Weikert C et al. Metabolic profiling reveals key metabolic features of renal cell carcinoma. J. Cell Mol. Med. 15(1), 109-118 (2011).
86. Hu ZP, Kim YM, Sowa MB et al. Metabolomic response of human skin tissue to low dose ionizing radiation. Mol. Biosyst. 8(7), 1979-1986 (2012).
87. Abaffy T, Möller M, Riemer DD, Milikowski C, Defazio RA. A case report-volatile metabolomic signature of malignant melanoma using matching skin as a control. J. Cancer Sci. Ther. 3(6), 140-144 (2011).
88. Huang CC, Lin WT, Hsu FL, Tsai PW, Hou CC. Metabolomics investigation of exercise-modulated changes in metabolism in rat liver after exhaustive and endurance exercises. Eur. J. Appl. Physiol. 108(3), 557-566 (2010).
89. Wang Y, Tao Y, Lin Y et al. Integrated analysis of serum and liver metabonome in liver transplanted rats by gas chromatography coupled with mass spectrometry. Anal. Chim. Acta 633(1), 65-70 (2009).
90. Wone B, Donovan ER, Hayes JP. Metabolomics of aerobic metabolism in mice selected for increased maximal metabolic rate. Comp. Biochem. Physiol. Part D Genomics Proteomics 6(4), 399-405 (2011).
91. Houtkooper RH, Argmann C, Houten SM et al. The metabolic footprint of aging in mice. Sci. Rep. 1, 134 (2011).
92. Brown M, Dunn WB, Dobson P et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst 134(7), 1322-1332 (2009).
93. Shimura D, Nakai G, Jiao Q et al. Metabolomic profiling analysis reveals chamber-dependent metabolite patterns in the mouse heart. Am. J. Physiol. Heart Circ. Physiol. 305(4), H494-H505 (2013).
94. Ooga T, Sato H, Nagashima A et al. Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol. Biosyst. 7(4), 1217-1223 (2011).
95. Hrydziuszko O, Silva MA, Perera MT et al. Application of metabolomics to investigate the process of human orthotopic liver transplantation: A proof-of-principle study. OMICS 14(2), 143-150 (2010).
96. Ly-Verdú S, Schaefer A, Kahle M et al. An untargeted metabolomic workflow to improve profiling-A combined metabolomic and proteomic approach. Anal. Chem. 85(16), 7713-7719 (2013).
97. Beyoǧlu D, Imbeaud S, Maurhofer O et al. Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology 58(1), 229-238 (2013).
98. Budczies J, Denkert C, Müller BM et al. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue-A GC-TOFMS based metabolomics study. BMC Genomics 13, 334 (2012).
99. Wu H, Xue R, Lu C et al. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(27), 3111-3117 (2009).
100. Wu H, Xue R, Tang Z et al. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry. Anal. Bioanal. Chem. 396(4), 1385-1395 (2010).
101. Lin S, Yang Z, Zhang X, Bian Z, Cai Z. Hippocampal metabolomics reveals 2,3,7,8-Tetrachlorodibenzo-p-dioxin toxicity associated with ageing in Sprague-Dawley rats. Talanta 85(2), 1007-1012 (2011).
102. Cubero-Leon E, Minier C, Rotchell JM, Hill EM. Metabolomic analysis of sex specific metabolites in gonads of the mussel, Mytilus edulis. Comp. Biochem. Physiol. Part D Genomics Proteomics 7(2), 212-219 (2012).
103. Liu SY, Zhang RL, Kang H, Fan ZJ, Du Z. Human liver tissue metabolic profiling research on hepatitis B virusrelated hepatocellular carcinoma. World J. Gastroenterol. 19(22), 3423-3432 (2013).
104. Clarke J D, Novak P, Lake AD et al. Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. Dig. Dis. Sci. 59(2), 365-374 (2014).
105. Parab GS, Rao R, Lakshminarayanan S, Bing YV, Moochhala SM, Swarup S. Data-driven optimization of metabolomics methods using rat liver samples. Anal. Chem. 81(4), 1315-1323 (2009).
106. Bojko B, Gorynski K, Gomez-Rios GA et al. Solid phase microextraction fills the gap in tissue sampling protocols. Anal. Chim. Acta 803, 75-81 (2013).
107. Pekkinen J, Olli K, Huotari A et al. Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach. Mol. Nutr. Food Res. 57(11), 1959-1968 (2013).
108. Sreekumar A, Poisson LM, Rajendiran TM et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231), 910-914 (2009).
109. Kelly AD, Breitkopf SB, Yuan M, Goldsmith J, Spentzos D, Asara JM. Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: Application in sarcoma. PLoS ONE 6(10), e25357 (2011).
110. de Bekker C, Smith PB, Patterson AD, Hughes DP. Metabolomics reveals the heterogeneous secretome of two entomopathogenic fungi to ex vivo cultured insect tissues. PLoS ONE 8(8), e70609 (2013)..